Rayonier Advanced Materials heads into the final trading day of September down 12.6% on the week, closing at $8.01, with short interest grinding higher and options positioning growing more defensive.
The short side has been quietly rebuilding momentum over the past month. Short interest has climbed 18.8% over the past 30 days, reaching 7.5% of the free float, about 5 million shares. The week-on-week move was flat, suggesting the monthly build has largely run its course for now, but the direction has been consistently upward since early September. Borrowing remains very cheap at 0.44%, and the lending pool is nowhere near tight, with availability running above 2,500%, meaning there is no friction for new shorts entering the stock. The ORTEX short score sits at 51.1, middling rather than extreme, and has barely moved over the past two weeks despite the price weakness.
Options traders have become measurably more cautious through the week. The put/call ratio rose to 0.41, up from a 52-week low of 0.17 just over a week ago on September 21, and now running 1.7 standard deviations above its 20-day average of 0.31. That is not an alarm level, but the pace of the shift is notable: the PCR has nearly doubled in eight trading sessions, tracking closely with the price decline. The stock's next earnings date is November 3, and it appears the options market is beginning to price in some downside protection ahead of that print.
The sole sell-side voice in the data is RBC Capital, which has maintained an Outperform rating throughout but trimmed its price target to $13 in mid-July, down from $14. At $8.01, that still implies more than 60% upside on the RBC view. The most recent change is now 75 days old, so the analyst picture is more dated than current. The bull case rests on raised Paperboard segment guidance, USMCA tariff compliance, and a weak dollar tailwind worth roughly $10 million. The bear case is harder to dismiss: the High-Yield Pulp segment posted an Adjusted EBITDA of negative $6 million, worse than forecast, and management has guided for further volume and price declines tied to tariff second-order effects and acetate destocking. Oversupply in the Chinese market adds a further structural headwind. Factor scores offer little comfort, with the short score rank in the 14th percentile, meaning RYAM scores lower on short-positioning metrics than 86% of the comparable universe.
The ownership picture is worth watching. Lightship Capital III LP holds 5.04% of the class under a Schedule 13D filing, making it an activist on the register. The position was trimmed marginally from 5.07% in a July amendment, but the activist designation remains active. Condire Investors holds the largest disclosed stake at 9.4%, unchanged as of June 30. BlackRock added 86,597 shares through August, bringing its stake to 7.0%. On the insider side, the only open-market trade in the past 90 days was a director sale of 1,931 shares at $9.13 in August, a small and low-significance transaction. The May block of director share grants across eight board members used transaction code M (option exercises), not open-market purchases, so they carry limited signal on conviction.
The last two earnings prints produced initial gains of 4.6% and 7.2% on the day but reversed sharply over the following five sessions, with five-day moves of negative 5.3% and negative 3.3%. That pattern, pop then fade, frames the November 3 date as much about whether pulp volumes stabilise as about any near-term catalyst from Paperboard. The combination of rising short interest, a tightening options stance, and a stock that has already lost 12.6% in a week makes the pace of acetate and ethers market recovery the central variable to track into the next print.
See the live data behind this article on ORTEX.
Open RYAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
